Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Exclamation mark hairs suggest early scalp disease, while white dots indicate it's chronic.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The document concludes that proper diagnosis and management of hair loss in children require a detailed examination and understanding of various hair disorders.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Middle-aged women with cicatricial alopecia/lichen planopilaris responded well to treatments like ketoconazole shampoo and steroids.

The new treatment improved keratosis pilaris symptoms and mood in 28 days.

Hair turning darker can be a sign of skin cancer.

Vitamin C deficiency can persist in high-risk patients despite supplementation.

Lifestyle changes, exercise, and antioxidants can help manage polycystic ovary syndrome.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

Surgical hair restoration was the best permanent solution for baldness in 2005.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Women with PCOS may be more likely to have gum disease than healthy women.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.